Rivastigmine: mechanism of action and pharmacology research
Rivastigmine is a cholinesterase inhibitor used to treat mild to moderate dementia in AD and PDD. Its mechanism and pharmacology will be introduced.
Aug 8，2025 Drugs
N-Acetyl Carnosine: Supplement with Antioxidant Properties and Ocular Applications
N-Acetyl carnosine, a stable form of L-carnosine, used in eye drops to potentially improve vision, with studies on age-related cataracts showing mixed evidence.
Aug 8，2025 API
Cisatracurium Besylate: Neuromuscular Blocker with Therapeutic and Antimicrobial Roles
Cisatracurium besylate aids anesthesia/ventilation via Hofmann elimination, shows anti-TB effects by inhibiting macrophage necroptosis.
Aug 6，2025 API
Triethyl Orthoacetate: Applications in Organic Synthesis and Esterification
Triethyl orthoacetate aids N-acetylation/esterification of amino acids and selective esterification of phosphonic acids in synthesis.
Aug 6，2025 Chemical Reagents
Metonitazene: A Potent Novel Opioid with Toxicological and Metabolic Insights
Metonitazene, a potent novel opioid, causes deaths, undergoes N/O-dealkylation, with metabolites aiding toxicological detection.
Aug 4，2025 API
2-Ethylhexyl Nitrate: Biodegradability and Microbial Degradation Pathways
2-Ethylhexyl nitrate, only refinery/soil microbes and Mycobacterium austroafricanum can partially degrade it, with metabolic constraints noted.
Aug 4，2025 Biochemical Engineering
2-Naphthalenethiol: Applications in Analysis, SAMs, and π-Stacking Studies
2-Naphthalenethiol aids SFN detection, forms SAMs on gold, and its dimer provides insights into π-stacking interactions.
Aug 4，2025 Chemical Materials
What are the Benefits of Malt Extract for the Humans?
Malt extract is a natural, functional ingredient that contains protein, essential amino acids, soluble fiber, vitamins B2, B3, and B6, the minerals iron, calcium, and potassium, and trace minerals suc
Jul 31，2025 Plant extracts
What are the indications and adverse reactions of Pazopanib?
Pazopanib is indicated for the first-line treatment of advanced renal cell carcinoma or for patients with advanced renal cell carcinoma who have received prior cytokine therapy.
Jul 30，2025 API
Indications and adverse reactions of ABT-199
Venetoclax (ABT-199) is an important anti-cancer drug jointly developed by Swiss pharmaceutical company Roche and US biotechnology company AbbVie.
Jul 30，2025 Biochemical Engineering